Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Verastem, Inc.
Condition: Malignant Pleural Mesothelioma
NCT02004028
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Company decided to discontinue trial to focus on development program next steps